In a new study published in Kidney International, researchers report that drugs known as SGLT2 inhibitors prevented age-related deterioration of kidney structure and...
SGLT2
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have rapidly reshaped the management of kidney and cardiovascular disease. Initially developed as glucose-lowering agents for...
